These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1206 related articles for article (PubMed ID: 25483679)

  • 1. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
    Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
    Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
    Fritz R; Orlinger KK; Hofmeister Y; Janecki K; Traweger A; Perez-Burgos L; Barrett PN; Kreil TR
    Vaccine; 2012 Feb; 30(6):1165-9. PubMed ID: 22178103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
    Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
    Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
    Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains.
    Hayasaka D; Goto A; Yoshii K; Mizutani T; Kariwa H; Takashima I
    Vaccine; 2001 Sep; 19(32):4774-9. PubMed ID: 11535329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test based on subtype-specific μ-capture IgM immunoassay can distinguish between infections of European and Siberian subtypes of tick-borne encephalitis virus.
    Levanov L; Jääskeläinen A; Vapalahti O
    J Clin Virol; 2015 Dec; 73():81-83. PubMed ID: 26580408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    Matveev AL; Kozlova IV; Stronin OV; Khlusevich YA; Doroshchenko EK; Baykov IK; Lisak OV; Emelyanova LA; Suntsova OV; Matveeva VA; Savinova JS; Tikunova NV
    PLoS One; 2019; 14(4):e0215075. PubMed ID: 30958863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
    Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
    J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroprevalence of tick-borne encephalitis virus (TBEV) among the residents of rural areas in Sinop, central Black-Sea region, Turkey].
    Güneş T; Poyraz O; Ataş M; Alim A
    Mikrobiyol Bul; 2010 Oct; 44(4):585-91. PubMed ID: 21063971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human.
    Leonova GN; Pavlenko EV
    Vaccine; 2009 May; 27(21):2899-904. PubMed ID: 19366574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
    Klockmann U; Bock HL; Kwasny H; Praus M; Cihlová V; Tomková E; Krivanec K
    Vaccine; 1991 Jan; 9(1):42-6. PubMed ID: 2008800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TICK-BORNE ENCEPHALITIS VIRUS: EPIDEMIOLOGICAL AND CLINICAL PICTURE, DIAGNOSIS AND PREVENTION].
    Vilibić-Čavlek T; Barbić L; Pandak N; Pem-Novosel I; Stevanović V; Kaić B; Mlinarić-Galinović G
    Acta Med Croatica; 2014 Dec; 68(4-5):393-404. PubMed ID: 26285473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.